Shattuck Labs, Inc.
STTKNasdaqCIK 1680367HealthcareFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-1306:07 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-032780 |
| 2023-12-2616:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-129205 |
| 2023-12-2216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-302156 |
| 2023-12-2107:31 ET | 8-K | 8.01 Other events | 0001193125-23-300388 |
| 2023-12-1306:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-293874 |
| 2023-11-0907:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001680367-23-000062 |
| 2023-11-0907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-23-000060 |
| 2023-08-1016:04 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001680367-23-000050 |
| 2023-08-1016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-23-000049 |
| 2023-05-2416:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-152998 |
| 2023-05-0916:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001680367-23-000035 |
| 2023-05-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-23-000033 |
| 2023-04-0616:30 ET | DEF 14A | Proxy statementPeriod 2023-05-23 | 0001193125-23-094058 |
| 2023-03-1017:22 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-23-067776 |
| 2023-02-2316:35 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001680367-23-000019 |
| 2023-02-2316:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-23-000017 |
| 2022-12-0920:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001827315-22-000003 |
| 2022-11-0906:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001680367-22-000034 |
| 2022-11-0816:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-22-000031 |
| 2022-08-1106:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-22-000021 |
| 2022-08-1106:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001680367-22-000020 |
| 2022-07-2916:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-206671 |
| 2022-06-1016:34 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-172003 |
| 2022-05-1206:03 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001680367-22-000015 |
| 2022-05-1206:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-22-000014 |
| 2022-04-2116:37 ET | DEF 14A | Proxy statementPeriod 2022-06-07 | 0001193125-22-113098 |
| 2022-03-1506:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-22-000007 |
| 2022-03-1506:02 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001680367-22-000005 |
| 2021-11-1517:52 ET | 8-K | 7.01 Regulation FD disclosure | 0001680367-21-000062 |
| 2021-11-0916:31 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001680367-21-000057 |
| 2021-11-0908:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-21-000052 |
| 2021-10-2816:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-311373 |
| 2021-08-1217:37 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001680367-21-000039 |
| 2021-08-1116:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-21-000035 |
| 2021-06-1017:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-187887 |
| 2021-05-1016:55 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001680367-21-000017 |
| 2021-05-1018:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-21-000013 |
| 2021-04-2217:25 ET | DEF 14A | Proxy statementPeriod 2021-06-08 | 0001193125-21-126933 |
| 2021-03-1621:01 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001680367-21-000008 |
| 2021-03-1517:06 ET | 8-K | 2.02 Results of operations | 0001680367-21-000005 |
| 2020-11-1316:10 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001680367-20-000012 |
| 2020-11-1318:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001680367-20-000009 |
| 2020-10-2317:20 ET | SC 13D | Ownership report, active investor | 0001193125-20-275604 |
| 2020-10-2317:20 ET | SC 13D | Ownership report, active investor | 0001193125-20-275600 |
| 2020-10-1517:23 ET | SC 13D | Ownership report, active investor | 0001104659-20-115359 |
| 2020-10-1417:18 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-269417 |
| 2020-10-0819:50 ET | S-1/A | Registration statement, amended | 0001193125-20-265736 |
| 2020-10-0508:07 ET | S-1/A | Registration statement, amended | 0001193125-20-263321 |
| 2020-09-1817:05 ET | S-1 | Registration statement | 0001193125-20-249204 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 12:15 ET. Listed shows no prices and gives no investment advice.